2020
DOI: 10.1016/j.tvjl.2020.105455
|View full text |Cite
|
Sign up to set email alerts
|

Sympathomimetics in veterinary species under anesthesia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
19
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(19 citation statements)
references
References 62 publications
0
19
0
Order By: Relevance
“…13,27 Noradrenaline is reported to have similar adrenergic agonist activity to dopamine acting via β1 and α1 receptors likely explaining the similar effects on CO, SVR and untimely improved BP seen in the studies in this CAT. 34 Unlike the some of the studies evaluating dopamine neither noradrenaline study reported UoP or other renal parameters preventing any comparison of the renal effects of these two drugs. 13,27 Currently there are no studies directly comparing noradrenaline and dopamine for treating hypotension in dogs.…”
Section: Critical Appraisal Of the Evidencementioning
confidence: 96%
See 1 more Smart Citation
“…13,27 Noradrenaline is reported to have similar adrenergic agonist activity to dopamine acting via β1 and α1 receptors likely explaining the similar effects on CO, SVR and untimely improved BP seen in the studies in this CAT. 34 Unlike the some of the studies evaluating dopamine neither noradrenaline study reported UoP or other renal parameters preventing any comparison of the renal effects of these two drugs. 13,27 Currently there are no studies directly comparing noradrenaline and dopamine for treating hypotension in dogs.…”
Section: Critical Appraisal Of the Evidencementioning
confidence: 96%
“…One study also demonstrated dopamine improved UoP suggesting increased renal blood flow and glomerular filtration rate (GFR) 33 . Dopamine is reported to have dose dependant effects on the cardiovascular system, at lower doses acting via dopamine (DA1) receptors predominately in renal vasculature, with further effects exerted via β1 and finally α1 adrenergic receptors with progressively higher doses thus increasing CO and SVR, respectively 34 . Studies in this review predominately used mid‐range dopamine (Table 4 – Studies 2, 3, 4, 5, 9 and 11) starting infusions at 7 μg/kg/min 12,22,31 or 5 μg/kg/min 30,32 and increasing up to 10 to 15 μg/kg/min.…”
Section: Critical Appraisal Of the Evidencementioning
confidence: 99%
“…Dopamine is less efficient at normalizing arterial blood pressure than norepinephrine and it has been associated with arrhythmias than norepinephrine (42), most likely because vasoconstrictor effects of dopamine are achieved with higher infusion rates, which also exacerbate beta-1 adrenergic effects (81). In addition, mortality is higher than in patients receiving norepinephrine (42).…”
Section: Vasopressorsmentioning
confidence: 99%
“…Phenylephrine is a pure alpha-1 agonist; therefore only vasoconstriction is expected from it, which may be detrimental in hypovolemic patients that also exhibit a reduction in cardiac output, unless contractility is supported with beta-1 agonists (81). Septic patients treated with phenylephrine had a higher mortality rate than patients treated with norepinephrine (82) and current recommendations from the guidelines for management of sepsis and septic shock state that phenylephrine use should be limited until more research is available (72).…”
Section: Vasopressorsmentioning
confidence: 99%
See 1 more Smart Citation